Friday, 13 Jul 2018

You are here

Time to Rethink Gout as a Chronic Disease

The current issue of JAMA has a perspective article on Gout’s bad rap as dietary disease rather than the complex, chronic inflammatory disorder that is ineffectively treated in many. 

The author and experts interviewed believe that the pipeline of new drugs for gout will fuel the future of evidence-based care and more informed lifestyle instruction.

Gout affects about 4% of adults in the United States. The growing number of older adults, who are more likely to have gout, is expected to increase the need for gout care.

"The disease of kings" is clearly a misnomer as gluttony and excess seldom stand in the way of better care.  Sadly, many with gout fail to recognize it as a form of arthritis,  A 2016 online survey showed that 71% didn’t know gout and that half with gout were embarrassed by their condition. 

Although diet is often implicated, evidence proving the benefits of strict avoidance are limited.  While red meat, alcohol, sugar-sweetened soft drinks, and seafood have been implicated, the ACR guideline suggests that avoidance of purine-rich organ meats (liver), shellfish and sardines may only improve serum uric acid levels by10% to 18%.

Many experts have noted the limitations and pitfalls with found with a dietary approach to gout. 

A real problem are the differing treatment approaches and understanding of gout by primary care physicians (PCPs) and rheumatologist, exemplified by their contrasting guidelines. The 2012 ACR focuses on a a treat-to-target approach with the goal of a uric acid levels below 6 mg/dL and the use of urate-lowering medications long-term with frequent monitoring.  Yet the 2016 American College of Physicians guideline only has a treat-to-symptoms approach emphasizing the use of anti-inflammatory medications to control flares and reserving uric acid-lowering therapy for patients with frequent flares, 

Discrepancies between the guidelines may be hampering patient care, and hopefully upcoming meetngs between the ACR and ACP may resolve these differences. The ACR’s gout guideline is scheduled for release in 2020.

Emerging evidence suggests that a chronic disease care model for gout, which simultaneously addresses uric acid levels, lifestyle, and dietary factors, may improve management and outcomes for patients with gout.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Obesity, Hypertension and Diuretics Drive Gout Risk

A recent metanalysis suggests that obesity, hypertension and diuretic use are associated with a two-fold increased risk of incident gout.

From a potential of 9923 articles, researchers analyzed 11 studies with data suitable for the meta-analysis.

Gout was 2.24 times more likely to occur in individuals with body mass index ≥ 30 kg/m2 (adjusted relative risk 2.24 (95% confidence interval) 1.76–2.86).

Public Citizen Pressures FDA to Pull Febuxostat

Public Citizen has petitioned the U.S. Food and Drug Administration (FDA) to remove Takeda's drug febuxostat (Uloric) from the market, citing the FDA's own warnings and evidence of serious cardiovascular harms. This follows on a recent FDA safety warning and NEJM paper citing cardiovascular concerns over febuxostat.

Gout Takeaways

The annual EULAR meeting just came to an end today. Rooms are gradually emptying out. People look both content to have updated their knowledge and relieved that four very busy days have concluded. Time to summarize.

Sons of Gout Study

The genetics and heritability of gout has suggested a higher risk in certain families.  A UK cohort study examined the prevalence of gout and monosodium urate (MSU) crystal deposition among those at risk (sons of gout patients) for gout and found a high incidence of hyperuricemia and MSU crystal deposition.

The Hazardous Highs and Lows of Uric Acid

Both high and low levels of uric acid were linked with increased risks of death, showing a U-shaped association between serum uric acid levels and all-cause, cardiovascular, and cancer mortality, Korean researchers reported.